{
  "nctId": "NCT03543254",
  "briefTitle": "\"Follow the Sutures\". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine",
  "officialTitle": "\"Follow the Sutures\". An Open Multicenter, Multinational Pilot Study to Explore Tolerability, Safety and Effect of a New Procedure for Injecting Botulinum Toxin in the Head Against Chronic Migraine",
  "protocolDocument": {
    "nctId": "NCT03543254",
    "filename": "Prot_002.pdf",
    "label": "Study Protocol",
    "date": "2018-03-20",
    "uploadDate": "2024-01-08T04:04",
    "size": 17239049,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03543254/document/Prot_002.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 20,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-05-01",
    "completionDate": "2021-01-01",
    "primaryCompletionDate": "2021-01-01",
    "firstSubmitDate": "2018-05-18",
    "firstPostDate": "2018-06-01"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Chronic migraine, as defined in the ICHD-3 beta version\n* Chronic migraine should have been present for at least Â½ year prior to evaluation for study inclusion\n* For women of child-bearing potential there must be no pregnancy or planned pregnancy during the study period, and use of highly effective contraception\n* Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to ICH GCP, and national/local regulations\n\nExclusion Criteria:\n\n* Diseases that are contraindications for use of Botulinum toxin A (Myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, other diseases interfering with neuromuscular function)\n* Allergy to Botulinum toxin A\n* Other primary or secondary headache disorder, including medication overuse headache (MOH). This means that at least one attempt to withdraw acute medication should have been performed earlier, but without success\n* Severe depression or other psychiatric disorder that may interfere with the treatment\n* Abuse of alcohol or illicit drugs\n* Use of more than one headache prophylactic medication, or change in type and dose of prophylactic medication \\< 28 days before start of baseline period\n* Previous exposure at any time to any botulinum toxin serotype\n* Infection at one or more injection site(s)\n* Having received extracranial nerve block, cervical facet injection, or other interventional procedure for headache within the prior 3 months\n* Use of opioids or barbiturate containing medication(s) \\> 10 days per month within the preceding 3 months\n* Participating in another trial that might affect the current study\n* Should not participate in the opinion of the investigator (e.g. not able to comply with study procedures).",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "64 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of Adverse Events",
        "description": "adverse events (other than clearly related to migraine) will be recorded in the diary by the patients and reviewed during the scheduled visits",
        "timeFrame": "12 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Injection Time",
        "description": "Time used for injection of Medicine measured by stopwatch",
        "timeFrame": "Week 1"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 19,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:54.201Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}